INVO Bioscience To Participate In Lytham Partners Winter 2021 Investor Conference

INVO Bioscience, Inc. (NASDAQ:INVO), a medical device company focused on commercializing the world's only in vivo culture system (IVC), INVOcell®, announced today that it will be participating in the Lytham

INVO Bioscience, Inc. (NASDAQ:INVO), a medical device company focused on commercializing the world's only in vivo culture system (IVC), INVOcell®, announced today that it will be participating in the Lytham Partners Winter 2021 Investor Conference taking place from December 13-16, 2021. During the event, the company will be participating in a webcasted Fireside Chat discussing the business and conducting 1×1 virtual investor meetings.

The webcasted Fireside Chat will be available for viewing at 11:00am ET on Monday, December 13, 2021 at https://wsw.com/webcast/lytham3/invo/2053560. The webcast will also be available for replay following the event.

To arrange a 1×1 meeting with management, please contact Lytham Partners at 1×1@lythampartners.com  or register at www.lythampartners.com/winter2021invreg.